EUVIMEDOpdag EUVIMED
Randomisierte kontrollierte StudieOpen access · CC BY-NC 4.0

Effect of Whey Protein Supplementation on Postoperative Outcomes After Gynecological Cancer Surgery: A Randomized Controlled Trial

Wiranchana Chitti iD, Putsarat Insin iD, Nisa Prueksaritanond iD

World Journal of Oncology · 2025-02 · 16 (1) · 70-82

DOI: 10.14740/wjon1990 ↗

At a glance

Randomisierte kontrollierte Studie in World Journal of Oncology, 2025-02. Written by Wiranchana Chitti and 2 co-authors. Institution: Department of Obstetrics and Gynecology, Rajavithi Hospital, Bangkok, Thailand. Cited 10 times so far (Crossref). The full text is freely available (open access, CC BY-NC 4.0).

AbstractSubjectsBibliografiske oplysningerCiteRelated studies

Abstract (original language)

Background

Whey protein's biochemical properties make it an ideal nutritional supplement for patients with cancer, especially in perioperative care. Thus, the present study aims to assess the efficacy of whey protein supplementation (WPS) compared to standard care in enhancing postoperative outcomes for patients undergoing comprehensive surgical staging for gynecological cancer.

Methods

In an open-label, randomized controlled trial conducted at Rajavithi Hospital between November 28, 2023 and July 8, 2024, 61 patients scheduled for comprehensive surgical staging were enrolled. Participants were randomized in a 1:1 ratio to either the WPS group (n = 30) or the control group (n = 31). The WPS group received isolated whey protein powder (20 g of protein per serving), administered at 6 pm before surgery and 6 am on the first postoperative day. The control group received standard postoperative care. The primary endpoint was the length of hospital stay (LOHS), with secondary outcomes including gastrointestinal function recovery, postoperative analgesic use, complications, and potential WPS-related adverse events such as transaminitis, acute kidney injury, and electrolyte imbalances.

Results

The WPS group had a significantly shorter LOHS than the control group (79.0 ± 6.7 vs. 93.3 ± 28.4 h, P = 0.021). Additionally, the WPS group demonstrated significant improvements in gastrointestinal function, with shorter times to first flatus (P 0.05). Furthermore, no WPS-related adverse events were reported.

Conclusion

The use of WPS in the perioperative operative management of gynecological cancer surgery yields promising results by significantly reducing the LOHS and accelerating the recovery of gastrointestinal function while maintaining a favorable safety profile.

Subjects

Author keywords

Gynecological cancer surgeryPostoperative outcomesRandomized controlled trialWhey protein supplementation

Authors and institutions

  • Department of Obstetrics and Gynecology, Rajavithi Hospital, Bangkok, Thailand.
  • College of Medicine, Rangsit University, Bangkok, Thailand.

ORCID profiles: Wiranchana Chitti, Putsarat Insin, Nisa Prueksaritanond

Cite

APA

Chitti, W., Insin, P., & Prueksaritanond, N. (2025). Effect of Whey Protein Supplementation on Postoperative Outcomes After Gynecological Cancer Surgery: A Randomized Controlled Trial. World Journal of Oncology, 16(1), 70-82. https://doi.org/10.14740/wjon1990

Vancouver

Chitti W, Insin P, Prueksaritanond N. Effect of Whey Protein Supplementation on Postoperative Outcomes After Gynecological Cancer Surgery: A Randomized Controlled Trial. World Journal of Oncology. 2025;16(1):70-82. doi:10.14740/wjon1990

BibTeX
@article{Chitti2025,
  author = {Chitti, Wiranchana and Insin, Putsarat and Prueksaritanond, Nisa},
  title = {Effect of Whey Protein Supplementation on Postoperative Outcomes After Gynecological Cancer Surgery: A Randomized Controlled Trial},
  journal = {World Journal of Oncology},
  year = {2025},
  volume = {16},
  number = {1},
  pages = {70--82},
  doi = {10.14740/wjon1990}
}
Start for free →